Infectious diseases society of America emerging infections network: Bridging the gap between clinical infectious diseases and public health

Clinical Infectious Diseases

Volumn 58, Issue 7, 2014, Pages 991-996

  Pillai, Satish K ^a   Beekmann, Susan E ^b   Santibanez, Scott ^a   Polgreen, Philip M ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Emerging infectious diseases; Infectious diseases physicians; Public health

Indexed keywords

CLINICAL CARE; CLINICAL MEDICINE; CLINICAL OBSERVATION; E-MAIL; FUTUROLOGY; HEALTH CARE; HEALTH CARE POLICY; HUMAN; INFECTION; MEDICAL SOCIETY; MONITORING; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC OPINION; REVIEW; TELECONFERENCE; TREND STUDY; COMMUNICABLE DISEASES, EMERGING; EPIDEMIOLOGICAL MONITORING; INFECTIOUS DISEASE MEDICINE; INFORMATION DISSEMINATION; SOCIAL NETWORK; UNITED STATES;

COMMUNICABLE DISEASES, EMERGING; ELECTRONIC MAIL; EPIDEMIOLOGICAL MONITORING; HUMANS; INFECTIOUS DISEASE MEDICINE; INFORMATION DISSEMINATION; PUBLIC HEALTH; SOCIAL NETWORKING; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84904131986     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit932     Document Type: Review

References (26)

1. Institute of Medicine. Emerging infections: microbial threats to health in the United States.Washington, DC: National Academy Press, 1992.
2. Centers for Disease Control and Prevention. Tracking a mystery disease: the detailed story of hantavirus pulmonary syndrome (HPS). Available at: http://www.cdc.gov/hantavirus/hps/history.html. Accessed 5 November 2013.
3. Hughes JM. Addressing emerging infectious disease threats - accomplishments and future plans. Emerg Infect Dis 1998; 4:360-1.
4. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States (executive summary). MMWR Recomm Rep 1994; 43(RR-5):1-18.
5. Strausbaugh LJ, Liedtke LA. The Emerging Infections Network electronic mail conference andWeb page. Clin Infect Dis 2001; 32:270-6.
6. Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Recomm Rep 2001; 50(RR-13): 1-36.
7. Beekmann SE, Diekema DJ, Huskins WC, et al. Diagnosing and reporting of central line-associated bloodstream infections. Infect Control Hospital Epidemiol 2012; 33:875-82.
8. Terranella A, Beekmann SE, Polgreen PM, Cohn A, Wu HM, Clark TA. Practice patterns of infectious disease physicians for management of meningococcal disease. Pediatr Infect Dis J 2012; 31:e208-12.
9. Iverson SA, Chiller T, Beekmann SE, Polgreen PM, Harris J. Recognition, diagnosis and treatment of Cryptococcus gattii infections in the United State: a survey of infectious disease physicians. Emerg Infect Dis 2012; 18:1012-5.
10. Marschall J, Lane MA, Beekmann SE, Polgreen PM, Babcock HM. Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agent 2013; 41:272-7.
11. Hersh AL, Newland JG, Beekmann SE, Polgreen PM, Gilbert DN. Unmet medical need in infectious diseases. Clin Infect Dis 2012; 54:1677-78.
12. Diekema D, Johannsson B, Herwaldt L, et al. Current practice in Staphylococcus aureus screening and decolonization. Infect Control Hospital Epidemiol 2011; 32:1042-44.
13. Dowell D, Polgreen PM, Beekmann SE, Workowski KA, Berman S, Peterman T. Management dilemmas in syphilis: a survey of infectious disease experts. Clin Infect Dis 2009; 49:1526-9.
14. Polgreen PM, Septimus E, Talbot TR, Beekmann SE, Helms C. Results of a national survey of infectious diseases specialists regarding influenza vaccination programs for healthcare workers. Infect Control Hospital Epidemiol 2010; 31:1063-65.
15. Polgreen PM, Septimus E, Parry MF, et al. Relationship of influenza vaccination declination statements and influenza vaccination rates in 22 U.S. hospitals. Infect Control Hospital Epidemiol 2008; 29:675-7.
16. Hersh AL, Beekmann SE, Polgreen PM, Zaoutis TE, Newland JG. Antimicrobial stewardship programs in pediatrics. Infect Control Hospital Epidemiol 2009; 30:1211-17.
17. Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hospital Epidemiol 2011; 32:367-74.
18. Banerjee R, Beekmann SE, Doby B, Polgreen PM, Rathore M, Hersh AL. Outpatient parenteral antimicrobial therapy (OPAT) practices among pediatric infectious diseases consultants: results of an Emerging Infections Network survey. J Pediatr Infect Dis 2013; 32:17-22.
19. Winthrop KL, Yamashita S, Beekmann SE, Polgreen PM, on behalf of the Infectious Diseases Society of America Emerging Infections Network. Mycobacterial and other serious infections in patients receiving anti-TNF and other newly approved biologic therapies; case-finding via the Emerging Infections Network. Clin Infect Dis 2008; 46: 1738-40.
20. Gundlapalli AV, Beekmann SE, Graham DR, Polgreen PM. Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists. Diagn Microbiol Infect Dis 2013; 75:256-9.
21. Abbo LM, Beekmann SE, Hooton TM, Johannsson B, Polgreen PM. Infectious diseases physician management of antimicrobial allergies. JAMA Int Med 2013; 173:1376-8.
22. Miller RA, Burdette SD, Levi M, Beekmann SE, Polgreen PM, Kuehnert MJ. Communication gaps for solid organ transplant transmitted infections among infectious diseases physicians. Transplant Infect Dis 2013; 15:8-13.
23. Beekmann SE, Gilbert D, Polgreen P. Toxicity of extended course linezolid: results of an Infectious Diseases Society of America Emerging Infections Network (EIN) survey. Diag Microbiol Infect Dis 2008; 62:407-10.
24. Banerjee R, Hersh A, Newland J, et al, on behalf of the Emerging Infections Network Hemolytic-Uremic Syndrome Study Group. S. pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J 2011; 30:736-39.
25. Tamma PD, Newland JG, Pannaraj PS, et al. The use of intravenous colistin among hospitalized children in the United States: results from a multicenter, case-series. Pediatr Infect Dis J 2013; 32:17-22.
26. Larson K, Levy J, Rome MG, Matte TD, Silver LD, Frieden TR. Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City. Public Health Rep 2006; 121:228-34.